Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term
<h4>Objective</h4> To assess in ART-naïve pregnant women randomized to efavirenz- versus raltegravir-based ART (IMPAACT P1081) whether pretreatment drug resistance (PDR) with minority frequency variants (<20% of individual’s viral quasispecies) affects antiretroviral treatment (ART)-s...
Main Authors: | Ceejay L. Boyce, Ingrid A. Beck, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David E. Shapiro, Esaú C. João, Mark H. Mirochnick, Lisa M. Frenkel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514603/?tool=EBI |
Similar Items
-
Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term.
by: Ceejay L Boyce, et al.
Published: (2022-01-01) -
Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir
by: Ingrid A. Beck, et al.
Published: (2024-07-01) -
Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
by: Ingrid A. Beck, et al.
Published: (2020-01-01) -
Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study.
by: Whitney E Harrington, et al.
Published: (2022-01-01) -
Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study
by: Whitney E. Harrington, et al.
Published: (2022-01-01)